{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:14:03Z","timestamp":1791346443245,"version":"4.3.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"The Ohio State University Comprehensive Cancer Center\u2014The James","award":["P30CA016058"],"award-info":[{"award-number":["P30CA016058"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["K01DA055696"],"award-info":[{"award-number":["K01DA055696"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U54CA287392"],"award-info":[{"award-number":["U54CA287392"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Many oral nicotine pouch (ONP) brands use synthetic nicotine, which typically contains a racemic (50:50) mixture of nicotine\u2019s two stereoisomers: S-nicotine and R-nicotine. Because tobacco-derived nicotine contains more than 99% S-nicotine, the effects of R-nicotine in humans are not well known. We compared systemic nicotine exposure and product appeal of ONPs containing more than 99% S-nicotine versus racemic nicotine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aims and Methods<\/jats:title>\n                  <jats:p>N\u2005=\u200518 adult smokers (Mage\u2005=\u200545 years, 66.7% male, 77.8% White) enrolled in a three-visit single-blind, randomized crossover study. During each visit, participants used one wintergreen-flavored, 3 mg nicotine ONP for 30 min following at least12 h nicotine abstinence. Study ONP #1 contained more than 99% S-nicotine and the other two study ONPs contained racemic nicotine (collapsed for analyses). Plasma nicotine assessments and measures of withdrawal relief occurred at t\u2005=\u20050, 5, 15, 30, 60, and 90 min; measures of product appeal were assessed following ONP use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Using the ONP with more than 99% S-nicotine resulted in greater plasma nicotine concentration from 15 to 90 min (p\u2005&amp;lt;\u2005.0001) and greater maximum plasma nicotine concentration than the ONPs with racemic nicotine (M\u2005=\u20059.9 ng\/mL [SD\u2005=\u20052.5] vs. M\u2005=\u20055.7 ng\/mL [SD\u2005=\u20052.8], respectively; p\u2005&amp;lt;\u2005.0001). Product liking and withdrawal relief were similar across ONPs, although participants reported more \u201cbad effects\u201d when using the ONP with more than 99% S-nicotine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Participants reported few subjective differences in ONPs according to nicotine stereoisomer, but plasma nicotine concentration was greater for ONPs using more than 99% S-nicotine. ONPs with more than 99% S-nicotine (vs. racemic nicotine) might be better substitutes for cigarettes, but research into other ONP characteristics (eg flavors, freebase nicotine) is needed to inform regulation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications<\/jats:title>\n                  <jats:p>Little is known about the effects of racemic (vs. S-) nicotine in humans. In a sample of adults who smoke cigarettes, we identified that oral nicotine pouches containing racemic nicotine exposed participants to less nicotine than oral nicotine pouches containing only S-nicotine, but both types of oral nicotine pouches held similar, moderate appeal. Additional research evaluating the roles that flavorings, total nicotine concentration, and freebase nicotine play in the abuse liability of oral nicotine pouches would inform comprehensive product regulations to support public health.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ntr\/ntae079","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T16:16:57Z","timestamp":1715098617000},"page":"658-665","source":"Crossref","is-referenced-by-count":8,"title":["Evaluating the Role of Nicotine Stereoisomer on Nicotine Pouch Abuse Liability: A Randomized Crossover Trial"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8574-7263","authenticated-orcid":false,"given":"Brittney","family":"Keller-Hamilton","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, The Ohio State University , Columbus, OH ,","place":["USA"]},{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Curran","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Alalwan","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Hinton","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle C","family":"Brinkman","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]},{"name":"College of Public Health, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-0597","authenticated-orcid":false,"given":"Ahmad","family":"El-Hellani","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]},{"name":"College of Public Health, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore L","family":"Wagener","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, The Ohio State University , Columbus, OH ,","place":["USA"]},{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Chrzan","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]},{"name":"College of Public Health, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]},{"name":"College of Public Health, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriya","family":"Suraapaneni","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6605-0743","authenticated-orcid":false,"given":"Darren","family":"Mays","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, The Ohio State University , Columbus, OH ,","place":["USA"]},{"name":"Comprehensive Cancer Center, Center for Tobacco Research, The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"issue":"E1","key":"2025032407551539900_CIT0001","first-page":"e145","article-title":"Tobacco companies introduce \u2018tobacco-free\u2019 nicotine pouches","volume":"29","author":"Robichaud","year":"2020","journal-title":"Tob Control."},{"issue":"3","key":"2025032407551539900_CIT0002","doi-asserted-by":"crossref","first-page":"e2022056586","DOI":"10.1542\/peds.2022-056586","article-title":"Adolescent use of flavored non-tobacco oral nicotine products","volume":"150","author":"Harlow","year":"2022","journal-title":"Pediatrics."},{"issue":"9","key":"2025032407551539900_CIT0003","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ntr\/ntab040","article-title":"Patterns of non-cigarette tobacco and nicotine use among current cigarette smokers and recent quitters: findings from the 2020 ITC Four Country Smoking and Vaping Survey","volume":"23","author":"Li","year":"2021","journal-title":"Nicotine Tob Res."},{"issue":"6","key":"2025032407551539900_CIT0004","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/tobaccocontrol-2021-057156","article-title":"Nicotine pouch product awareness, interest and ever use among US adults who smoke, 2021","volume":"32","author":"Hrywna","year":"2022","journal-title":"Tob Control."},{"issue":"5","key":"2025032407551539900_CIT0005","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1080\/01480545.2021.1925691","article-title":"Chemical characterization of tobacco-free \u201cmodern\u201d oral nicotine pouches and their position on the toxicant and risk continuums","volume":"45","author":"Azzopardi","year":"2021","journal-title":"Drug Chem Toxicol."},{"issue":"3","key":"2025032407551539900_CIT0006","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/ntr\/nty129","article-title":"A conceptual framework for understanding multiple tobacco product use and the impact of regulatory action","volume":"21","author":"Pacek","year":"2019","journal-title":"Nicotine Tob Res."},{"issue":"8","key":"2025032407551539900_CIT0007","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/ntr\/ntaa239","article-title":"Examining market trends in smokeless tobacco sales in the United States: 2011","volume":"23","author":"Delnevo","year":"2020","journal-title":"Nicotine Tob Res."},{"issue":"1","key":"2025032407551539900_CIT0008","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/ntr\/ntac204","article-title":"\u201cTobacco-free\u201d nicotine pouches: risk perceptions, awareness, susceptibility, and use among young adults in the United States","volume":"25","author":"Morean","year":"2022","journal-title":"Nicotine Tob Res."},{"issue":"7","key":"2025032407551539900_CIT0009","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/chir.22866","article-title":"Enantiomeric composition of nicotine in tobacco leaf, cigarette, smokeless tobacco, and e-liquid by normal phase high-performance liquid chromatography","volume":"30","author":"Zhang","year":"2018","journal-title":"Chirality."},{"issue":"e1","key":"2025032407551539900_CIT0010","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1136\/tobaccocontrol-2021-056626","article-title":"Synthetic nicotine has arrived","volume":"32","author":"Jordt","year":"2021","journal-title":"Tob Control."},{"issue":"12","key":"2025032407551539900_CIT0011","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3109\/00498258809042260","article-title":"Species variation and stereoselectivity in the metabolism of nicotine enantiomers","volume":"18","author":"Nwosu","year":"1988","journal-title":"Xenobiotica."},{"issue":"12","key":"2025032407551539900_CIT0012","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.2042-7158.1988.tb06289.x","article-title":"Enantioselective metabolism during continuous administration of S-(\u2212)-and R-(+)-nicotine isomers to Guinea-Pigs","volume":"40","author":"Nwosu","year":"1988","journal-title":"J Pharm Pharmacol."},{"issue":"5","key":"2025032407551539900_CIT0013","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jps.2600770508","article-title":"Disposition kinetics of nicotine and cotinine enantiomers in rabbits and beagle dogs","volume":"77","author":"Jacob","year":"1988","journal-title":"J Pharm Sci."},{"issue":"1","key":"2025032407551539900_CIT0014","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0006-8993(94)90343-3","article-title":"Effects of chronic treatment with (+)-and (\u2212)-nicotine on nicotinic acetylcholine receptors and","volume":"644","author":"Zhang","year":"1994","journal-title":"Brain Res."},{"issue":"2","key":"2025032407551539900_CIT0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0022-3565(25)33223-4","article-title":"The effects of","volume":"222","author":"Ikushima","year":"1982","journal-title":"J Pharmacol Exp Ther."},{"issue":"1","key":"2025032407551539900_CIT0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(98)00384-7","article-title":"Nicotine stereoisomers and cotinine stimulate prostaglandin E2 but inhibit thromboxane B2 and leukotriene E4 synthesis in whole blood","volume":"353","author":"Saareks","year":"1998","journal-title":"Eur J Pharmacol."},{"key":"2025032407551539900_CIT0017","author":"Rep. Jeffries","year":"2022"},{"issue":"4","key":"2025032407551539900_CIT0018","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1520-636X(1996)8:4<295::AID-CHIR1>3.0.CO;2-F","article-title":"Chiral purity determination of tobacco alkaloids and nicotine-like compounds by 1H NMR spectroscopy in the presence of 1, 1\u02b9-binaphthyl-2, 2\u02b9-diylphosphoric acid","volume":"8","author":"Ravard","year":"1996","journal-title":"Chirality."},{"issue":"7","key":"2025032407551539900_CIT0019","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1021\/acs.chemrestox.1c00192","article-title":"Determination of (R)-(+)- and (S)-(","volume":"34","author":"Duell","year":"2021","journal-title":"Chem Res Toxicol."},{"issue":"3","key":"2025032407551539900_CIT0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch Gen Psychiatry."},{"issue":"3","key":"2025032407551539900_CIT0021","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/tobaccocontrol-2016-053344","article-title":"Comparison of a preferred versus non-preferred waterpipe tobacco flavour: subjective experience, smoking behaviour and toxicant exposure","volume":"27","author":"Leavens","year":"2018","journal-title":"Tob Control."},{"issue":"6","key":"2025032407551539900_CIT0022","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1037\/pha0000145","article-title":"Preliminary validity of the modified cigarette evaluation questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content","volume":"25","author":"Arger","year":"2017","journal-title":"Exp Clin Psychopharmacol."},{"issue":"3","key":"2025032407551539900_CIT0023","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/add.16355","article-title":"Evaluating the effects of nicotine concentration on the appeal and nicotine delivery of oral nicotine pouches among rural and Appalachian adults who smoke cigarettes: a randomized cross-over study","volume":"119","author":"Keller-Hamilton","year":"2023","journal-title":"Addiction."},{"issue":"11","key":"2025032407551539900_CIT0024","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1007\/s00213-021-05948-y","article-title":"Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on!\u00ae nicotine pouches compared to combustible cigarettes","volume":"238","author":"Rensch","year":"2021","journal-title":"Psychopharmacology (Berl)."},{"issue":"2","key":"2025032407551539900_CIT0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s13318-021-00742-9","article-title":"A randomised study to investigate the nicotine pharmacokinetics of Oral nicotine pouches and a combustible cigarette","volume":"47","author":"McEwan","year":"2022","journal-title":"Eur J Drug Metab Pharmacokinet."},{"issue":"3","key":"2025032407551539900_CIT0026","doi-asserted-by":"crossref","first-page":"1000184","DOI":"10.4172\/2155-6105.1000184","article-title":"Nicotine absorption from smokeless tobacco modified to adjust pH","volume":"5","author":"Pickworth","year":"2014","journal-title":"J Addict Res Ther."},{"issue":"192","key":"2025032407551539900_CIT0027","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-540-69248-5_2","article-title":"Nicotine chemistry, metabolism, kinetics and biomarkers","author":"Benowitz","year":"2009","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"2025032407551539900_CIT0028","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/tobaccocontrol-2021-056899","article-title":"Cross-promotion of nicotine pouches by leading cigarette brands","volume":"32","author":"Talbot","year":"2021","journal-title":"Tob Control."},{"issue":"9","key":"2025032407551539900_CIT0029","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/ntr\/ntab030","article-title":"Characterization of total and unprotonated (Free) nicotine content of nicotine pouch products","volume":"23","author":"Stanfill","year":"2021","journal-title":"Nicotine Tob Res."},{"issue":"11","key":"2025032407551539900_CIT0030","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/ntr\/ntab069","article-title":"Harm reduction associated with dual use of cigarettes and e-cigarettes in Black and Latino smokers: secondary analyses from a randomized controlled e-cigarette switching trial","volume":"23","author":"Arnold","year":"2021","journal-title":"Nicotine Tob Res."}],"container-title":["Nicotine and Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntae079\/57440032\/ntae079.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/27\/4\/658\/57440032\/ntae079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/27\/4\/658\/57440032\/ntae079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T12:38:04Z","timestamp":1742992684000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/27\/4\/658\/7666581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5,7]]},"published-print":{"date-parts":[[2025,3,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntae079","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,5,7]]}}}